Wird geladen...
Chlorpromazine versus piperacetazine for schizophrenia
BACKGROUND: Schizophrenia is a severe mental disorder with a prevalence of about 1% among the general population. It is listed among the top 10 causes of disability‐adjusted life years (DALYs) worldwide. Antipsychotics are the mainstay treatment. Piperacetazine has been reported to be as clinically...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2018
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517193/ https://ncbi.nlm.nih.gov/pubmed/30378678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011709.pub2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|